L
LIfT BioSciences
Biotech & Life Sciences · London, United Kingdom · Founded 2016
Lift Biosciences is a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy MoreLess
LIfT Biosciences® has a breakthrough allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) that allows us to produce different types of Immunomodulatory Alpha Neutrophils (IMAN®s) at scale from iPSCs for a wide range of different purposes as a mono or combo.
Talent graph
LIfT BioSciences's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on LIfT BioSciences's cap table
Sourced from Dealroom's funding and investor records.






Global footprint
Where LIfT BioSciences has talent and traffic
team presence
Market sentiment
What the market is saying about LIfT BioSciences
An AI-synthesized read of the highest-engagement posts about LIfT BioSciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LIfT BioSciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.